¿¬±¸µ¿ÇâÁ¤º¸
Á¦¸ñ [ÃֽŠ¿¬±¸µ¿Çâ] ÀÓ»óÀÇÇÐºÐ¾ß 19¡¯ 7¿ù Å°¿öµå ºÐ¼®
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

 

 

ÃֽŠÀÇ°úÇР ¿¬±¸µ¿Ç⠺м® : ÀÓ»óÀÇÇÐºÐ¾ß 2019³â 7¿ù Å°¿öµå ºÐ¼®

 

 

2019³â 7¿ù ÃֽŠÀÇ°úÇÐ ¿¬±¸µ¿ÇâÀ» ÆľÇÇϱâ À§ÇÏ¿© ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ´Â ÀÓ»óÀÇÇко߸¦ Æ÷ÇÔÇÏ¿© ±âÃÊÀÇÇÐ,  ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ, °£È£ÇÐ, Ä¡ÀÇÇко߸¦ Æ÷ÇÔÇÏ¿© ÀÇ°úÇÐºÐ¾ß Å°¿öµå ºÐ¼®À» ¼öÇàÇÏ¿´´Ù. ÀÚ·á´Â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)¸¦ ÀÌ¿ëÇÏ¿´À¸¸ç, ±¹³» Àú³Î ¹ßÇ¥³í¹®°ú ¹Ì±¹±¹¸³º¸°Ç¿ø PubMed DB¿¡ À妽ºµÈ ±¹¿Ü Àú³Î¿¡ ¹ßÇ¥µÈ ³í¹®À» ºÐ¼®´ë»óÀ¸·Î ÇÏ¿´´Ù. 



 

  ±×¸² 1. Çѱ¹ÀÇ°úÇÐ ¿¬±¸µ¿ÇâºÐ¼® : ÀÓ»óÀÇÇÐ ºÐ¾ß 7¿ù Å°¿öµåµ¿Çâ 


 

 

7¿ù¿¡ Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ ±¹³» ¹× ±¹¿Ü¿¡ ¹ßÇ¥ÇÑ ³í¹® Àüü 5,253Æí Áß¿¡¼­ ÀÓ»óÀÇÇко߿¡ ÇØ´çÇÏ´Â ³í¹®Àº 2,729ÆíÀ¸·Î ÀüüÀÇ 52%¸¦ Â÷ÁöÇÏ¿© Àü¿ù 47.3%(n=1,549)¿¡ ºñ±³ÇÏ¿© 4.7% Áõ°¡µÈ ¹ßÇ¥°æÇâÀ» ³ªÅ¸³»¾ú´Ù.  

 




 

 Ç¥ 1.  ÀÇ°úÇÐ ÃֽŠ¿¬±¸µ¿Ç⠺м® : ÀÓ»óÀÇÇÐºÐ¾ß 2019³â 7¿ù ¿¬±¸µ¿Ç⠺м®

(KMbase: Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º 2019³â 7¿ù ±¹³»,±¹¿ÜÀú³Î ¹ßÇ¥±âÁØ n=2,729)

Å°¿öµå ¼øÀ§

ÀÓ»óÀÇÇÐ ¿¬±¸µ¿Çâ Å°¿öµå

1

Neoplasms

2

BMI

3

Paediatric

4

Area Under Curve

5

DNA

6

Periodicals

7

LC-ESI-MS

8

Chronic Obstructive Lung Disease

9

MicroRNAs

10

Ankle

11

DCIS

12

Interleukin-6

13

CAD

14

Stability

15

Electroencephalography

16

Depression

17

Cognitive disorder

18

Ovarian Neoplasms

19

HIV

20

Chronic kidney disease

 





 

ÀÓ»óÀÇÇкоßÀÇ ±¹³», ±¹¿Ü 7¿ù ³í¹®¹ßÇ¥½Ã¿¡ ÀúÀÚ°¡ ÀÔ·ÂÇÑ Å°¿öµå ºÐ¼® °á°ú´Â Ankle, Area Under Curve, BMI, CAD, Chronic kidney disease, Chronic Obstructive Lung Disease, Cognitive disorder, DCIS, Depression, DNA, Electroencephalography, HIV, Interleukin-6, LC-ESI-MS, MicroRNAs, Neoplasms, Ovarian Neoplasms, Paediatric, Periodicals, Stability µîÀÇ Å°¿öµå°¡ »óÀ§·Î ÃâÇöÇÏ¿´´Ù.  

 

ÀÓ»óÀÇÇÐºÐ¾ß 7¿ù Å°¿öµå ¿¬±¸µ¿ÇâºÐ¼®Àº Çѱ¹ ¿¬±¸ÀÚ°¡ ¹ßÇ¥ÇÑ KMbase (Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º) ±âÁØÀ¸·Î  ±¹³» Àú³Î¹ßÇ¥ 1,424Æí, ±¹¿Ü Àú³Î¹ßÇ¥(PubMed ±âÁØ) 1,305ÆíÀÌ ºÐ¼®´ë»óÀ¸·Î ÀÌ¿ëµÇ¾ú´Ù. 




 


2019-08-19 ¿ÀÈÄ 1:44:57, Á¶È¸¼ö : 1680